Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 8(10): e77166, 2013.
Article in English | MEDLINE | ID: mdl-24204762

ABSTRACT

Smooth muscle α actin (Acta2) expression is largely restricted to smooth muscle cells, pericytes and specialized fibroblasts, known as myofibroblasts. Liver injury, associated with cirrhosis, induces transformation of resident hepatic stellate cells into liver specific myofibroblasts, also known as activated cells. Here, we have used in vitro and in vivo wound healing models to explore the functional role of Acta2 in this transformation. Acta2 was abundant in activated cells isolated from injured livers but was undetectable in quiescent cells isolated from normal livers. Both cellular motility and contraction were dramatically increased in injured liver cells, paralleled by an increase in Acta2 expression, when compared with quiescent cells. Inhibition of Acta2 using several different techniques had no effect on cytoplasmic actin isoform expression, but led to reduced cellular motility and contraction. Additionally, Acta2 knockdown was associated with a significant reduction in Erk1/2 phosphorylation compared to control cells. The data indicate that Acta2 is important specifically in myofibroblast cell motility and contraction and raise the possibility that the Acta2 cytoskeleton, beyond its structural importance in the cell, could be important in regulating signaling processes during wound healing in vivo.


Subject(s)
Actins/genetics , Chemical and Drug Induced Liver Injury/genetics , Hepatic Stellate Cells/metabolism , Myofibroblasts/metabolism , Wound Healing/genetics , Actins/antagonists & inhibitors , Actins/metabolism , Animals , Carbon Tetrachloride , Cell Differentiation , Cell Movement , Cell Proliferation , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Embryo, Mammalian , Gene Expression Regulation , Hepatic Stellate Cells/pathology , Male , Mice , Mitogen-Activated Protein Kinase 1/genetics , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/genetics , Mitogen-Activated Protein Kinase 3/metabolism , Myofibroblasts/pathology , Phosphorylation , Primary Cell Culture , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Rats , Rats, Sprague-Dawley , Signal Transduction
2.
Dev Biol ; 363(1): 1-14, 2012 Mar 01.
Article in English | MEDLINE | ID: mdl-22123032

ABSTRACT

Smooth muscle α-actin (Acta2) is one of six highly conserved mammalian actin isoforms that appear to exhibit functional redundancy. Nonetheless, we have postulated a specific functional role for the smooth muscle specific isoform. Here, we show that Acta2 deficient mice have a remarkable mammary phenotype such that dams lacking Acta2 are unable to nurse their offspring effectively. The phenotype was rescued in cross fostering experiments with wild type mice, excluding a developmental defect in Acta2 null pups. The mechanism for the underlying phenotype is due to myoepithelial dysfunction postpartum resulting in precocious involution. Further, we demonstrate a specific defect in myoepithelial cell contractility in Acta2 null mammary glands, despite normal expression of cytoplasmic actins. We conclude that Acta2 specifically mediates myoepithelial cell contraction during lactation and that this actin isoform therefore exhibits functional specificity.


Subject(s)
Actins/physiology , Apoptosis/physiology , Lactation/physiology , Mammary Glands, Animal/physiology , Actins/genetics , Actins/metabolism , Animals , Animals, Newborn , Apoptosis/genetics , Body Weight , Cells, Cultured , Epithelial Cells/metabolism , Epithelial Cells/physiology , Female , Gene Expression , Immunoblotting , Lactation/drug effects , Lactation/genetics , Male , Mammary Glands, Animal/cytology , Mammary Glands, Animal/metabolism , Maternal Behavior , Mice , Mice, 129 Strain , Mice, Inbred BALB C , Mice, Knockout , Oxytocics/pharmacology , Oxytocin/pharmacology , Pregnancy , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Isoforms/physiology , Reverse Transcriptase Polymerase Chain Reaction
3.
Am J Physiol Gastrointest Liver Physiol ; 297(1): G27-33, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19299580

ABSTRACT

Endothelin-1 (ET-1), a potent vasoactive peptide, plays an important role in the pathogenesis of liver disease and portal hypertension. Two major endothelin receptors (ET-A and ET-B) mediate biological effects, largely on the basis of their known downstream signaling pathways. We hypothesized that the different receptors are likely to mediate divergent effects in portal hypertensive mice. Liver fibrosis and cirrhosis and portal hypertension were induced in 8-wk-old male BALB/c mice by gavage with carbon tetrachloride (CCl4). Portal pressure was recorded acutely during intravenous infusion of endothelin receptor antagonists in normal or portal hypertensive mice. In vivo microscopy was used to monitor sinusoidal dynamics. Additionally, the effect of chronic exposure to endothelin antagonists was assessed in mice during induction of fibrosis and cirrhosis with CCl4 for 8 wk. Intravenous infusion of ET-A receptor antagonists into normal and cirrhotic mice reduced portal pressure whereas ET-B receptor antagonism increased portal pressure. A mixed endothelin receptor antagonist also significantly reduced portal pressure. Additionally, the ET-A receptor antagonist caused sinusoidal dilation, whereas the ET-B receptor antagonist caused sinusoidal constriction. Chronic administration of each the endothelin receptor antagonists during the induction of fibrosis and portal hypertension led to reduced fibrosis, a significant reduction in portal pressure, and altered sinusoidal dynamics relative to controls. Acute effects of endothelin receptor antagonists are likely directly on the hepatic and sinusoidal vasculature, whereas chronic endothelin receptor antagonism appears to be more complicated, likely affecting fibrogenesis and the hepatic microcirculation. The data imply a relationship between hepatic fibrogenesis or fibrosis and vasomotor responses.


Subject(s)
Endothelin A Receptor Antagonists , Endothelin B Receptor Antagonists , Hypertension, Portal/prevention & control , Liver Cirrhosis, Experimental/prevention & control , Liver/drug effects , Pyrrolidines/pharmacology , Sulfonamides/pharmacology , Animals , Atrasentan , Endothelins/metabolism , Hypertension, Portal/chemically induced , Hypertension, Portal/metabolism , Hypertension, Portal/physiopathology , Infusions, Intravenous , Liver/blood supply , Liver/metabolism , Liver/pathology , Liver Circulation/drug effects , Liver Cirrhosis, Experimental/chemically induced , Liver Cirrhosis, Experimental/metabolism , Liver Cirrhosis, Experimental/physiopathology , Male , Mice , Mice, Inbred C57BL , Portal Pressure/drug effects , Pyrrolidines/administration & dosage , Receptor, Endothelin A/metabolism , Receptor, Endothelin B/metabolism , Sulfonamides/administration & dosage , Time Factors , Vasoconstriction/drug effects , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...